Apotex Wins As High Court Denies Pfizer Appeal

Law360, New York (October 1, 2007, 12:00 AM EDT) -- The U.S. Supreme Court declined to hear Pfizer Inc.'s appeal in its patent feud with Apotex Inc. over blockbuster blood-pressure drug Norvasc. As a result, an appellate court's March ruling that Pfizer's patent is unenforceable will prevail.

On Monday, the first day of its 2007 fall term, the High Court denied Pfizer's appeal for a writ of certiorari. Pfizer filed that request in May, soon after the U.S. Court of Appeals for the Federal Circuit denied its request for an en banc rehearing, leaving intact its...
To view the full article, register now.